1 OTC Anti-Infective Products Market Overview 1.1 OTC Anti-Infective Products Product Overview 1.2 OTC Anti-Infective Products Market Segment by Type 1.2.1 Antifungals 1.2.2 Antiseptic 1.2.3 Antiparasitics 1.3 Global OTC Anti-Infective Products Market Size by Type (2015-2026) 1.3.1 Global OTC Anti-Infective Products Market Size Overview by Type (2015-2026) 1.3.2 Global OTC Anti-Infective Products Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global OTC Anti-Infective Products Sales Market Share Breakdown by Type (2015-2026) 1.3.2.2 Global OTC Anti-Infective Products Revenue Market Share Breakdown by Type (2015-2026) 1.3.2.3 Global OTC Anti-Infective Products Average Selling Price (ASP) by Type (2015-2026) 1.3.3 Global OTC Anti-Infective Products Market Size Forecast by Type (2021-2026) 1.3.3.1 Global OTC Anti-Infective Products Sales Market Share Breakdown by Application (2021-2026) 1.3.3.2 Global OTC Anti-Infective Products Revenue Market Share Breakdown by Application (2021-2026) 1.3.3.3 Global OTC Anti-Infective Products Average Selling Price (ASP) by Application (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America OTC Anti-Infective Products Sales Breakdown by Type (2015-2026) 1.4.2 Europe OTC Anti-Infective Products Sales Breakdown by Type (2015-2026) 1.4.3 Asia-Pacific OTC Anti-Infective Products Sales Breakdown by Type (2015-2026) 1.4.4 Latin America OTC Anti-Infective Products Sales Breakdown by Type (2015-2026) 1.4.5 Middle East and Africa OTC Anti-Infective Products Sales Breakdown by Type (2015-2026) 2 Global OTC Anti-Infective Products Market Competition by Company 2.1 Global Top Players by OTC Anti-Infective Products Sales (2015-2020) 2.2 Global Top Players by OTC Anti-Infective Products Revenue (2015-2020) 2.3 Global Top Players OTC Anti-Infective Products Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers OTC Anti-Infective Products Manufacturing Base Distribution, Sales Area, Product Type 2.5 OTC Anti-Infective Products Market Competitive Situation and Trends 2.5.1 OTC Anti-Infective Products Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by OTC Anti-Infective Products Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2019) 2.7 Date of Key Manufacturers Enter into OTC Anti-Infective Products Market 2.8 Key Manufacturers OTC Anti-Infective Products Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global OTC Anti-Infective Products Status and Outlook by Region (2015-2026) 3.1 Global OTC Anti-Infective Products Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global OTC Anti-Infective Products Market Size Market Share by Region (2015-2020) 3.2.1 Global OTC Anti-Infective Products Sales Market Share by Region (2015-2020) 3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Region (2015-2020) 3.2.3 Global OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global OTC Anti-Infective Products Market Size Market Share by Region (2021-2026) 3.3.1 Global OTC Anti-Infective Products Sales Market Share by Region (2021-2026) 3.3.2 Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2026) 3.3.3 Global OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026) 3.4 North America OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 3.4.1 North America OTC Anti-Infective Products Revenue YoY Growth (2015-2026) 3.4.2 North America OTC Anti-Infective Products Sales YoY Growth (2015-2026) 3.5 Asia-Pacific OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 3.5.1 Asia-Pacific OTC Anti-Infective Products Revenue YoY Growth (2015-2026) 3.5.2 Asia-Pacific OTC Anti-Infective Products Sales YoY Growth (2015-2026) 3.6 Europe OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 3.6.1 Europe OTC Anti-Infective Products Revenue YoY Growth (2015-2026) 3.6.2 Europe OTC Anti-Infective Products Sales YoY Growth (2015-2026) 3.7 Latin America OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 3.7.1 Latin America OTC Anti-Infective Products Revenue YoY Growth (2015-2026) 3.7.2 Latin America OTC Anti-Infective Products Sales YoY Growth (2015-2026) 3.8 Middle East and Africa OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 3.8.1 Middle East and Africa OTC Anti-Infective Products Revenue YoY Growth (2015-2026) 3.8.2 Middle East and Africa OTC Anti-Infective Products Sales YoY Growth (2015-2026) 4 Global OTC Anti-Infective Products by Application 4.1 OTC Anti-Infective Products Segment by Application 4.1.1 Hospital Pharmacies 4.1.2 Drug Stores 4.1.3 Retail Stores 4.1.4 E-Commerce 4.2 Global OTC Anti-Infective Products Sales by Application: 2015 VS 2020 VS 2026 4.3 Global OTC Anti-Infective Products Historic Sales by Application (2015-2020) 4.4 Global OTC Anti-Infective Products Forecasted Sales by Application (2021-2026) 4.5 Key Regions OTC Anti-Infective Products Market Size by Application 4.5.1 North America OTC Anti-Infective Products by Application 4.5.2 Europe OTC Anti-Infective Products by Application 4.5.3 Asia-Pacific OTC Anti-Infective Products by Application 4.5.4 Latin America OTC Anti-Infective Products by Application 4.5.5 Middle East and Africa OTC Anti-Infective Products by Application 5 North America OTC Anti-Infective Products Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America OTC Anti-Infective Products Sales Market Share by Country (2015-2020) 5.1.2 North America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America OTC Anti-Infective Products Sales Market Share by Country (2021-2026) 5.2.2 North America OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) 5.3 North America Market Size YoY Growth by Country 5.3.1 U.S. OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 5.3.2 Canada OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 6 Europe OTC Anti-Infective Products Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe OTC Anti-Infective Products Sales Market Share by Country (2015-2020) 6.1.2 Europe OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe OTC Anti-Infective Products Sales Market Share by Country (2021-2026) 6.2.2 Europe OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) 6.3 Europe Market Size YoY Growth by Country 6.3.1 Germany OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 6.3.2 France OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 6.3.3 U.K. OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 6.3.4 Italy OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 6.3.5 Russia OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7 Asia-Pacific OTC Anti-Infective Products Market Size by Country (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Country (2015-2020) 7.1.1 Asia-Pacific OTC Anti-Infective Products Sales Market Share by Country (2015-2020) 7.1.2 Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Country (2021-2026) 7.2.1 Asia-Pacific OTC Anti-Infective Products Sales Market Share by Country (2021-2026) 7.2.2 Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) 7.3 Asia-Pacific Market Size YoY Growth by Country 7.3.1 China OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.2 Japan OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.3 South Korea OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.4 India OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.5 Australia OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.6 Taiwan OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.7 Indonesia OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.8 Thailand OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.9 Malaysia OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.10 Philippines OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 7.3.11 Vietnam OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 8 Latin America OTC Anti-Infective Products Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America OTC Anti-Infective Products Sales Market Share by Country (2015-2020) 8.1.2 Latin America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America OTC Anti-Infective Products Sales Market Share by Country (2021-2026) 8.2.2 Latin America OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) 8.3 Latin America Market Size YoY Growth by Country 8.3.1 Mexico OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 8.3.2 Brazil OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 8.3.3 Argentina OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 9 Middle East and Africa OTC Anti-Infective Products Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) 9.3 Middle East and Africa Market Size YoY Growth by Country 9.3.1 Turkey OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 9.3.2 Saudi Arabia OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 9.3.3 U.A.E OTC Anti-Infective Products Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in OTC Anti-Infective Products Business 10.1 GlaxoSmithKline 10.1.1 GlaxoSmithKline Corporation Information 10.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue 10.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered 10.1.5 GlaxoSmithKline Recent Development 10.2 Merck 10.2.1 Merck Corporation Information 10.2.2 Merck Description, Business Overview and Total Revenue 10.2.3 Merck OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.2.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered 10.2.5 Merck Recent Development 10.3 Pfizer 10.3.1 Pfizer Corporation Information 10.3.2 Pfizer Description, Business Overview and Total Revenue 10.3.3 Pfizer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.3.4 Pfizer OTC Anti-Infective Products Products Offered 10.3.5 Pfizer Recent Development 10.4 Novartis 10.4.1 Novartis Corporation Information 10.4.2 Novartis Description, Business Overview and Total Revenue 10.4.3 Novartis OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Novartis OTC Anti-Infective Products Products Offered 10.4.5 Novartis Recent Development 10.5 Abbott 10.5.1 Abbott Corporation Information 10.5.2 Abbott Description, Business Overview and Total Revenue 10.5.3 Abbott OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Abbott OTC Anti-Infective Products Products Offered 10.5.5 Abbott Recent Development 10.6 Sanofi 10.6.1 Sanofi Corporation Information 10.6.2 Sanofi Description, Business Overview and Total Revenue 10.6.3 Sanofi OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.6.4 Sanofi OTC Anti-Infective Products Products Offered 10.6.5 Sanofi Recent Development 10.7 Bristol-Myers Squibb 10.7.1 Bristol-Myers Squibb Corporation Information 10.7.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue 10.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered 10.7.5 Bristol-Myers Squibb Recent Development 10.8 Roche 10.8.1 Roche Corporation Information 10.8.2 Roche Description, Business Overview and Total Revenue 10.8.3 Roche OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.8.4 Roche OTC Anti-Infective Products Products Offered 10.8.5 Roche Recent Development 10.9 NanoViricides 10.9.1 NanoViricides Corporation Information 10.9.2 NanoViricides Description, Business Overview and Total Revenue 10.9.3 NanoViricides OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.9.4 NanoViricides OTC Anti-Infective Products Products Offered 10.9.5 NanoViricides Recent Development 10.10 Novabay Pharmaceuticals 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 OTC Anti-Infective Products Product Category, Application and Specification 10.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2015-2020) 10.10.4 Main Business Overview 10.10.5 Novabay Pharmaceuticals Recent Development 10.11 Optimer Pharmaceuticals 10.11.1 Optimer Pharmaceuticals Corporation Information 10.11.2 Optimer Pharmaceuticals Description, Business Overview and Total Revenue 10.11.3 Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.11.4 Optimer Pharmaceuticals OTC Anti-Infective Products Products Offered 10.11.5 Optimer Pharmaceuticals Recent Development 10.12 Basilea Pharmaceutica 10.12.1 Basilea Pharmaceutica Corporation Information 10.12.2 Basilea Pharmaceutica Description, Business Overview and Total Revenue 10.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.12.4 Basilea Pharmaceutica OTC Anti-Infective Products Products Offered 10.12.5 Basilea Pharmaceutica Recent Development 10.13 MerLion Pharma 10.13.1 MerLion Pharma Corporation Information 10.13.2 MerLion Pharma Description, Business Overview and Total Revenue 10.13.3 MerLion Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2015-2020) 10.13.4 MerLion Pharma OTC Anti-Infective Products Products Offered 10.13.5 MerLion Pharma Recent Development 11 OTC Anti-Infective Products Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 OTC Anti-Infective Products Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 OTC Anti-Infective Products Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Company of Antifungals Table 2. Major Company of Antiseptic Table 3. Major Players of Antiparasitics Table 4. Global OTC Anti-Infective Products Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 5. Global OTC Anti-Infective Products Sales (K Units) by Type (2015-2020) (K Units) Table 6. Global OTC Anti-Infective Products Sales Share by Type (2015-2020) Table 7. Global OTC Anti-Infective Products Revenue (Million USD) by Type (2015-2020) Table 8. Global OTC Anti-Infective Products Revenue Share by Type (2015-2020) Table 9. Global OTC Anti-Infective Products Average Selling Price (ASP) (USD/Unit) by Type (2015-2020) Table 10. Global OTC Anti-Infective Products Sales by Type (2021-2026) (K Units) Table 11. Global OTC Anti-Infective Products Sales Share by Type (2021-2026) Table 12. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2021-2026) Table 13. Global OTC Anti-Infective Products Revenue Share by Type (2021-2026) Table 14. Global OTC Anti-Infective Products Average Selling Price (ASP) (USD/Unit) by Type (2021-2026) Table 15. North America OTC Anti-Infective Products Sales (USD/Unit) by Type (2015-2020) Table 16. Europe OTC Anti-Infective Products Sales (USD/Unit) by Type (2015-2020) Table 17. Asia-Pacific OTC Anti-Infective Products Sales (USD/Unit) by Type (2015-2020) Table 18. Latin America OTC Anti-Infective Products Sales (USD/Unit) by Type (2015-2020) Table 19. Middle East and Africa OTC Anti-Infective Products Sales (USD/Unit) by Type (2015-2020) Table 20. Global OTC Anti-Infective Products Sales (K Units) by Company (2015-2020) Table 21. Global OTC Anti-Infective Products Sales Share by Company (2015-2020) Table 22. Global OTC Anti-Infective Products Revenue (Million US$) by Company (2015-2020) Table 23. Global OTC Anti-Infective Products Revenue Share by Company (2015-2020) Table 24. Global Market OTC Anti-Infective Products Average Selling Price (USD/Unit) by Company (2015-2020) Table 25. Global OTC Anti-Infective Products Top Manufacturers Manufacturing Base Distribution and Sales Area Table 26. Global OTC Anti-Infective Products Top Manufacturers Product Category Table 27. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2019 Table 29. Date of Key Manufacturers Enter into OTC Anti-Infective Products Market Table 30. Key Manufacturers OTC Anti-Infective Products Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global OTC Anti-Infective Products Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 33. Global OTC Anti-Infective Products Sales (K Units) by Region (2015-2020) Table 34. Global OTC Anti-Infective Products Sales Market Share by Region (2015-2020) Table 35. Global OTC Anti-Infective Products Revenue (US$ Million) by Region (2015-2020) Table 36. Global OTC Anti-Infective Products Revenue Market Share by Region (2015-2020) Table 37. Global OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 38. Global OTC Anti-Infective Products Sales (K Units) by Region (2021-2026) Table 39. Global OTC Anti-Infective Products Sales Market Share by Region (2021-2026) Table 40. Global OTC Anti-Infective Products Revenue (US$ Million) by Region (2021-2026) Table 41. Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2026) Table 42. Global OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 43. Global OTC Anti-Infective Products Sales (K Units) by Application: 2015 VS 2020 VS 2026 Table 44. Global OTC Anti-Infective Products Sales (K Units) by Application (2015-2020) Table 45. Global OTC Anti-Infective Products Sales Share by Application (2015-2020) Table 46. Global OTC Anti-Infective Products Sales (K Units) by Application (2021-2026) Table 47. Global OTC Anti-Infective Products Sales Share by Application (2021-2026) Table 48. North America OTC Anti-Infective Products Sales (K Units) by Application (2015-2020) Table 49. North America Sales OTC Anti-Infective Products Market Share by Application (2015-2020) Table 50. Europe OTC Anti-Infective Products Sales (K Units) by Application (2015-2020) Table 51. Europe Sales OTC Anti-Infective Products Market Share by Application In 2019 Table 52. Asia-Pacific OTC Anti-Infective Products Sales (K Units) by Application (2015-2020) Table 53. Asia-Pacific Sales OTC Anti-Infective Products Market Share by Application In 2019 Table 54. Latin America OTC Anti-Infective Products Sales (K Units) by Application (2015-2020) Table 55. Latin America Sales OTC Anti-Infective Products Market Share by Application In 2019 Table 56. Middle East and Africa OTC Anti-Infective Products Sales (K Units) by Application (2015-2020) Table 57. Middle East and Africa OTC Anti-Infective Products Sales Share by Application (2015-2020) Table 58. North America OTC Anti-Infective Products Sales (K Units) by Country (2015-2020) Table 59. North America OTC Anti-Infective Products Sales Market Share by Country (2015-2020) Table 60. North America OTC Anti-Infective Products Revenue (US$ Million) by Country (2015-2020) Table 61. North America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) Table 62. North America OTC Anti-Infective Products Sales (K Units) by Country (2021-2026) Table 63. North America OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 64. North America OTC Anti-Infective Products Revenue (US$ Million) by Country (2021-2026) Table 65. North America OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) Table 66. Europe OTC Anti-Infective Products Sales (K Units) by Country (2015-2020) Table 67. Europe OTC Anti-Infective Products Sales Market Share by Country (2015-2020) Table 68. Europe OTC Anti-Infective Products Revenue (US$ Million) by Country (2015-2020) Table 69. Europe OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) Table 70. Europe OTC Anti-Infective Products Sales (K Units) by Country (2021-2026) Table 71. Europe OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 72. Europe OTC Anti-Infective Products Revenue (US$ Million) by Country (2021-2026) Table 73. Europe OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) Table 74. Asia-Pacific OTC Anti-Infective Products Sales (K Units) by Region (2015-2020) Table 75. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Region (2015-2020) Table 76. Asia-Pacific OTC Anti-Infective Products Revenue (US$ Million) by Region (2015-2020) Table 77. Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Region (2015-2020) Table 78. Asia-Pacific OTC Anti-Infective Products Sales (K Units) by Region (2021-2026) Table 79. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Region (2021-2026) Table 80. Asia-Pacific OTC Anti-Infective Products Revenue (US$ Million) by Region (2021-2026) Table 81. Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Region (2021-2026) Table 82. Latin America OTC Anti-Infective Products Sales (K Units) by Country (2015-2020) Table 83. Latin America OTC Anti-Infective Products Sales Market Share by Country (2015-2020) Table 84. Latin America OTC Anti-Infective Products Revenue (US$ Million) by Country (2015-2020) Table 85. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) Table 86. Latin America OTC Anti-Infective Products Sales (K Units) by Country (2021-2026) Table 87. Latin America OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 88. Latin America OTC Anti-Infective Products Revenue (US$ Million) by Country (2021-2026) Table 89. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) Table 90. Middle East and Africa OTC Anti-Infective Products Sales (K Units) by Country (2015-2020) Table 91. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2015-2020) Table 92. Middle East and Africa OTC Anti-Infective Products Revenue (US$ Million) by Country (2015-2020) Table 93. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2015-2020) Table 94. Middle East and Africa OTC Anti-Infective Products Sales (K Units) by Country (2021-2026) Table 95. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2021-2026) Table 96. Middle East and Africa OTC Anti-Infective Products Revenue (US$ Million) by Country (2021-2026) Table 97. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2021-2026) Table 98. GlaxoSmithKline Corporation Information Table 99. GlaxoSmithKline Description and Business Overview Table 100. GlaxoSmithKline OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. GlaxoSmithKline OTC Anti-Infective Products Product Table 102. GlaxoSmithKline Recent Development Table 103. Merck Corporation Information Table 104. Merck Description and Business Overview Table 105. Merck OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Merck OTC Anti-Infective Products Product Table 107. Merck Recent Development Table 108. Pfizer Corporation Information Table 109. Pfizer Description and Business Overview Table 110. Pfizer OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Pfizer OTC Anti-Infective Products Product Table 112. Pfizer Recent Development Table 113. Novartis Corporation Information Table 114. Novartis Description and Business Overview Table 115. Novartis OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Novartis OTC Anti-Infective Products Product Table 117. Novartis Recent Development Table 118. Abbott Corporation Information Table 119. Abbott Description and Business Overview Table 120. Abbott OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Abbott OTC Anti-Infective Products Product Table 122. Abbott Recent Development Table 123. Sanofi Corporation Information Table 124. Sanofi Description and Business Overview Table 125. Sanofi OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. Sanofi OTC Anti-Infective Products Product Table 127. Sanofi Recent Development Table 128. Bristol-Myers Squibb Corporation Information Table 129. Bristol-Myers Squibb Description and Business Overview Table 130. Bristol-Myers Squibb OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. Bristol-Myers Squibb OTC Anti-Infective Products Product Table 132. Bristol-Myers Squibb Recent Development Table 133. Roche Corporation Information Table 134. Roche Description and Business Overview Table 135. Roche OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. Roche OTC Anti-Infective Products Product Table 137. Roche Recent Development Table 138. NanoViricides Corporation Information Table 139. NanoViricides Description and Business Overview Table 140. NanoViricides OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 141. NanoViricides OTC Anti-Infective Products Product Table 142. NanoViricides Recent Development Table 143. Novabay Pharmaceuticals Corporation Information Table 144. Novabay Pharmaceuticals Description and Business Overview Table 145. Novabay Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 146. Novabay Pharmaceuticals OTC Anti-Infective Products Product Table 147. Novabay Pharmaceuticals Recent Development Table 148. Optimer Pharmaceuticals Corporation Information Table 149. Optimer Pharmaceuticals Description and Business Overview Table 150. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 151. Optimer Pharmaceuticals OTC Anti-Infective Products Product Table 152. Optimer Pharmaceuticals Recent Development Table 153. Basilea Pharmaceutica Corporation Information Table 154. Basilea Pharmaceutica Description and Business Overview Table 155. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 156. Basilea Pharmaceutica OTC Anti-Infective Products Product Table 157. Basilea Pharmaceutica Recent Development Table 158. MerLion Pharma Corporation Information Table 159. MerLion Pharma Description and Business Overview Table 160. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 161. MerLion Pharma OTC Anti-Infective Products Product Table 162. MerLion Pharma Recent Development Table 163. Key Raw Materials Lists Table 164. Raw Materials Key Suppliers Lists Table 165. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 166. Key Challenges Table 167. Market Risks Table 168. Distributors List Table 169. OTC Anti-Infective Products Downstream Customers Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. OTC Anti-Infective Products Product Picture Figure 2. Global OTC Anti-Infective Products Revenue (Million USD) Status and Outlook (2015-2026) Figure 3. Global OTC Anti-Infective Products Sales (K Units) Status and Outlook (2015-2026) Figure 4. Product Picture of Antifungals Figure 5. Global Antifungals Sales (K Units) and Growth Rate (2015-2020) Figure 6. Product Picture of Antiseptic Figure 7. Global Antiseptic Sales (K Units) and Growth Rate (2015-2020) Figure 8. Product Picture of Antiparasitics Figure 9. Global Antiparasitics Sales (K Units) and Growth Rate (2015-2020) Figure 10. Global OTC Anti-Infective Products Revenue and Growth Rate by Type (US$ Million) Figure 11. Global OTC Anti-Infective Products Sales Market Share by Type (2015-2020) Figure 12. Global OTC Anti-Infective Products Sales Market Share by Type in 2019 Figure 13. Global OTC Anti-Infective Products Revenue Share by Type (2015-2020) Figure 14. Global OTC Anti-Infective Products Revenue Market Share by Type in 2019 Figure 15. Global OTC Anti-Infective Products Sales Market Share by Type (2021-2026) Figure 16. Global OTC Anti-Infective Products Sales Market Share by Type In 2019 Figure 17. Global OTC Anti-Infective Products Revenue Share by Type (2021-2026) Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Type In 2019 Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by OTC Anti-Infective Products Sales in 2019 Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by OTC Anti-Infective Products Revenue in 2019 Figure 21. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. North America OTC Anti-Infective Products Revenue (US$ Million) and Growth Rate (2015-2026) Figure 23. North America OTC Anti-Infective Products Sales YoY Growth (2015-2026) (K Units) Figure 24. Asia-Pacific OTC Anti-Infective Products Revenue (US$ Million) and Growth Rate (2015-2026) Figure 25. Asia-Pacific OTC Anti-Infective Products Sales YoY Growth (2015-2026) (K Units) Figure 26. Europe OTC Anti-Infective Products Revenue (US$ Million) and Growth Rate (2015-2026) Figure 27. Europe OTC Anti-Infective Products Sales YoY Growth (2015-2026) (K Units) Figure 28. Latin America OTC Anti-Infective Products Revenue (US$ Million) and Growth Rate (2015-2026) Figure 29. Latin America OTC Anti-Infective Products Sales YoY Growth (2015-2026) (K Units) Figure 30. Middle East and Africa OTC Anti-Infective Products Revenue (US$ Million) and Growth Rate (2015-2026) Figure 31. Middle East and Africa OTC Anti-Infective Products Sales YoY Growth (2015-2026) (K Units) Figure 32. Hospital Pharmacies Examples Figure 33. Drug Stores Examples Figure 34. Retail Stores Examples Figure 35. E-Commerce Examples Figure 36. U.S. OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 37. U.S. OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 38. Canada OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 39. Canada OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 40. Germany OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 41. Germany OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 42. France OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 43. France OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 44. U.K. OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 45. U.K. OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 46. Italy OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 47. Italy OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 48. Russia OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 49. Russia OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 50. China OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 51. China OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 52. Japan OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 53. Japan OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 54. South Korea OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 55. South Korea OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 56. India OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 57. India OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 58. Australia OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 59. Australia OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 60. Taiwan OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 61. Taiwan OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 62. Indonesia OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 63. Indonesia OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 64. Thailand OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 65. Thailand OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 66. Malaysia OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 67. Malaysia OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 68. Philippines OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 69. Philippines OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 70. Vietnam OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 71. Vietnam OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 72. Mexico OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 73. Mexico OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 74. Brazil OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 75. Brazil OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 76. Argentina OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 77. Argentina OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 78. Turkey OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 79. Turkey OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 80. Saudi Arabia OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 81. Saudi Arabia OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 82. U.A.E OTC Anti-Infective Products Sales (K Units) (2015-2026) Figure 83. U.A.E OTC Anti-Infective Products Revenue (US$ Million) (2015-2026) Figure 84. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 85. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 86. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. NanoViricides Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Novabay Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Optimer Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Basilea Pharmaceutica Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. MerLion Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Key Raw Materials Price Figure 98. OTC Anti-Infective Products Manufacturing Cost Structure Figure 99. OTC Anti-Infective Products Industrial Chain Analysis Figure 100. Porter's Five Forces Analysis Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Bottom-up and Top-down Approaches for This Report Figure 104. Data Triangulation Figure 105. Key Executives Interviewed

GlaxoSmithKline Merck Pfizer Novartis Abbott Sanofi Bristol-Myers Squibb Roche NanoViricides Novabay Pharmaceuticals Optimer Pharmaceuticals Basilea Pharmaceutica MerLion Pharma